Wargacki, Adam J.
Wörner, Tobias P.
van de Waterbeemd, Michiel
Ellis, Daniel
Heck, Albert J. R. http://orcid.org/0000-0002-2405-4404
King, Neil P. http://orcid.org/0000-0002-2978-4692
Funding for this research was provided by:
National Science Foundation (CHE 1629214)
Article History
Received: 15 October 2020
Accepted: 15 January 2021
First Online: 9 February 2021
Competing interests
: N.P.K. is a co-founder, shareholder, and chair of the scientific advisory board of Icosavax, Inc., a biotechnology company that has licensed patents related to the materials described from the University of Washington. All other authors declare no competing interests.